| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.24▼ | 1.22▲ | 1.23▼ | 1.28▼ | 1.18▲ |
| MA10 | 1.23▼ | 1.24▼ | 1.25▼ | 1.26▼ | 1.08▲ |
| MA20 | 1.22▲ | 1.26▼ | 1.28▼ | 1.20▲ | 1.14▲ |
| MA50 | 1.24▼ | 1.28▼ | 1.28▼ | 1.05▲ | 1.01▲ |
| MA100 | 1.26▼ | 1.28▼ | 1.23▲ | 1.12▲ | 0.96▲ |
| MA200 | 1.28▼ | 1.22▲ | 1.17▲ | 1.00▲ | 4.30▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.003▲ | -0.003▼ | -0.007▼ | 0.002▲ | 0.013▲ |
| RSI | 49.224▼ | 40.034▼ | 41.193▼ | 55.495▲ | 55.082▲ |
| STOCH | 74.286 | 18.472▼ | 22.563 | 65.469 | 66.490 |
| WILL %R | -37.500 | -62.500 | -72.727 | -48.276 | -33.231 |
| CCI | 45.000 | -47.531 | -89.824 | 17.677 | 73.434 |
|
Monday, June 16, 2025 04:31 AM
Gossamer Bio, Inc. (Nasdaq: GOSS), a late-stage, clinical biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial hypertension ...
|
|
Saturday, May 17, 2025 05:14 AM
Gossamer Bio, Inc. (NASDAQ:GOSS) Q1 2025 Earnings Call Transcript May 15, 2025 Gossamer Bio, Inc. beats earnings expectations. Reported EPS is $-0.16, expectations were $-0.18. Bryan Giraudo - COO ...
|
|
Thursday, May 15, 2025 02:15 PM
Gossamer Bio (GOSS) came out with a quarterly loss of $0.16 per share versus the Zacks Consensus Estimate of a loss of $0.18. This compares to loss of $0.19 per share a year ago. These figures are ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 13/06/25 | 1.27 | 1.29 | 1.20 | 1.24 | 1,126,516 |
| 12/06/25 | 1.28 | 1.31 | 1.25 | 1.27 | 1,038,474 |
| 11/06/25 | 1.25 | 1.37 | 1.25 | 1.29 | 1,670,924 |
| 10/06/25 | 1.32 | 1.34 | 1.24 | 1.245 | 1,488,648 |
| 09/06/25 | 1.34 | 1.38 | 1.29 | 1.33 | 981,332 |
| 06/06/25 | 1.26 | 1.355 | 1.26 | 1.33 | 1,428,232 |
| 05/06/25 | 1.26 | 1.275 | 1.22 | 1.26 | 718,950 |
| 04/06/25 | 1.21 | 1.29 | 1.21 | 1.26 | 1,430,623 |
| 03/06/25 | 1.17 | 1.2388 | 1.16 | 1.22 | 1,436,552 |
| 02/06/25 | 1.15 | 1.18 | 1.10 | 1.155 | 1,591,069 |
|
|
||||
|
|
||||
|
|